FDA Inspection 829271 — Regenerative Biologics Inc.

Regenerative Biologics Inc. — FEI 1000307669

The FDA completed an inspection of Regenerative Biologics Inc. on May 1, 2013 in Alachua, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 1, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Alachua, FL (United States)

Citations

IDCFRDescription
1232221 CFR 1271.160(b)(4)Training of personnel

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.